Regenerative potential of embryonic notochordal nucleus pulposus progenitors
Regenerative potential of embryonic notochordal nucleus pulposus progenitors
批准号:
9225462
负责人:
Neil Malhotra
金额:
$21.94万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-03 至 2019-05-31
关键词:
AddressAllelesBiologicalBiological Response Modifier TherapyCell Differentiation processCell SeparationCellsDepositionDevelopmentDiseaseEmbryoEmbryonic DevelopmentExhibitsExtracellular MatrixGrowth FactorHealthHydrostatic PressureImageImpairmentInjectableIntervertebral disc structureLow Back PainMapsMechanicsMediatingModelingMolecular ProfilingMusNatural regenerationOperative Surgical ProceduresPainPatternPopulationPositioning AttributePropertyProteoglycanRoleSignal PathwaySignal TransductionSourceStem cellsStructureSymptomsTherapeuticTimeTissuesTransgenic MiceWorkbasecell growthcell motilitydisc regenerationeffective therapyexperienceimprovedin vivoin vivo Modelinterestintervertebral disk degenerationmigrationmouse modelnotochordnovelnovel therapeuticsnucleus pulposuspostnatalprogenitorreduce symptomsregenerativespine bone structuretargeted treatmenttooltranscriptome sequencingtreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Lumbar intervertebral disc degeneration is a cascade of cellular, structural and mechanical changes
that is strongly implicated as a cause of low back pain. The central nucleus pulposus (NP) is implicated in the
initiation of this degenerative cascade, where decreasing proteoglycan content and an associated reduction in
hydrostatic pressure impair the ability of the NP to effectively engage the surrounding annulus fibrosus and to
evenly distribute and transfer compressive loads between the vertebrae. There is a critical need for therapies
for disc degeneration that restore disc structure and mechanical function by directly addressing the underlying
biological causes. A key challenge to developing effective biological treatments for disc degeneration is the
need to recapitulate the structural complexity and specialized extracellular matrix of the component tissues,
which comprise cells of multiple developmental lineages. Here we propose to address this challenge by
directly applying developmental paradigms to establish an optimized biological disc regeneration
strategy. Embryonic and postnatal disc formation is regulated by cells derived from the notochord. These cells
secrete an array of growth factors that regulate cell migration, proliferation, differentiation and extracellular
matrix deposition, and ultimately, directly give rise to the NP itself. There is therefore intense interest in
identifying notochordal cell-secreted factors and applying them to develop improved therapeutic strategies for
disc regeneration. The ideal stage to investigate the regenerative potential of notochordal cells is when they
are most actively contributing to embryonic and early postnatal disc development. Therefore the overall
objective of this proposal is to establish the regenerative potential of embryonic, notochord-derived
nucleus pulposus progenitor cells (NDCs). Specifically, we will define the growth factor expression profile of
NDCs at key stages of embryonic and postnatal disc development using whole transcriptome sequencing
(RNA-Seq), and directly establish the regenerative potential of NDCs as a function of developmental stage
using an in vivo mouse model of disc degeneration. The results of this work will provide a roadmap for
optimizing cell and growth factor-based therapeutics for disc regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamic heterogeneity of nucleus pulposus cells from development to degeneration
-
批准号:10401258
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2021
-
负责人:Neil Malhotra
-
依托单位:
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells
-
批准号:10337343
-
项目类别:
-
资助金额:$54.59万
-
财政年份:2021
-
负责人:Neil Malhotra
-
依托单位:
Neutralizing the degenerate disc microenvironment to enhance the efficacy of therapeutic stem cells
-
批准号:10536642
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2021
-
负责人:Neil Malhotra
-
依托单位:
海外基金